首页> 外国专利> COMPOSITIONS AND KITS USEFUL IN DIAGNOSIS/PROGNOSIS/ASSESSMENT OF BRAIN INJURIES

COMPOSITIONS AND KITS USEFUL IN DIAGNOSIS/PROGNOSIS/ASSESSMENT OF BRAIN INJURIES

机译:在脑损伤的诊断/预后/评估中有用的成分和试剂盒

摘要

To provide compositions and methods useful in the diagnosis/prognosis/assessment of brain injuries.SOLUTION: A method for identifying which patients with traumatic brain injury (TBI) require a head computerized tomography (CT) scan for diagnosing acute intracranial pathology, comprises the steps of: (a) obtaining or collecting a sample from the patient; (b) measuring the levels of one or more biomarkers in the blood sample obtained from the patient, in which step the biomarkers comprise glial fibrillary acidic protein (GFAP), S100B, metallothionein 3 (MT3), neuron specific enolase (NSE) and intracellular adhesion molecule 5 (ICAM5); and (c) identifying the patient as requiring or not requiring a head CT scan on the basis of the measured levels of one or more of biomarkers comprising GFAP, S100B, MT3, NSE, and ICAM5.SELECTED DRAWING: Figure 1
机译:为了提供对脑损伤的诊断/预后/评估有用的组合物和方法。解决方案:一种用于识别哪些颅脑损伤(TBI)患者需要进行头部计算机断层扫描(CT)扫描以诊断急性颅内病理的方法,包括以下步骤的:(a)从患者那里获取或收集样品; (b)测量从患者获得的血液样本中的一种或多种生物标志物的水平,该步骤中的生物标志物包括神经胶质原纤维酸性蛋白(GFAP),S100B,金属硫蛋白3(MT3),神经元特异性烯醇化酶(NSE)和细胞内粘附分子5(ICAM5); (c)根据测得的一种或多种生物标记物(包括GFAP,S100B,MT3,NSE和ICAM5)的水平,将患者识别为需要进行头部CT扫描。图1

著录项

  • 公开/公告号JP2020034567A

    专利类型

  • 公开/公告日2020-03-05

    原文格式PDF

  • 申请/专利权人 JOHNS HOPKINS UNIV;

    申请/专利号JP20190195925

  • 申请日2019-10-29

  • 分类号G01N33/53;G01N33/543;C12N9;C07K14/47;C07K16/18;C12M1/34;

  • 国家 JP

  • 入库时间 2022-08-21 11:35:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号